Keratin-based materials

01Overview and value chain

Markers: [EC: Circular Bioeconomy Strategy & REACH Regulation | OECD: bio-materials | Regulator: FDA (US), REACH (EU), NMPA (CN)]

Keratin-based materials convert poultry feather waste and off-grade wool — millions of tons of which are otherwise landfilled or incinerated each year because keratin resists natural decomposition — into soluble, biocompatible proteins for wound care, cosmetics, coatings and tissue engineering. Keraplast Technologies markets Functional Keratin® ingredients across personal care, nutraceuticals and wound care, including keraGEN-IV®, an ingestible keratin-derived peptide product marketed to support keratin metabolism in hair, skin and nails. In China, the Institute of Process Engineering (IPE) of the Chinese Academy of Sciences — which operates the world’s first thousand-ton-scale ionic-liquid-based regenerated cellulose fiber project in Henan province — has also published research on keratin-reinforced silicone-ionic-liquid elastomer composites for pressure-sensor applications, applying the same green-solvent extraction expertise to a second protein feedstock. In Germany, Fraunhofer IAP has demonstrated keratin as a multifunctional filler for coatings and published research on a keratin-based 3D-printed tissue substitute, while UK-based Kerax Limited supplies bulk hot-liquid keratin gel products (its keraGEL® line) derived from wool-processing byproducts.

The key directions of keratin-based materials are:

1. Reductive keratin extraction: breaking keratin’s strong disulfide (S-S) bonds with thiol reagents or sodium sulfite in concentrated urea solutions to yield soluble keratin (keratose/kerateine) without degrading the peptide backbone.
2. Tissue-engineering scaffolds: 3D porous keratin matrices for cell-culture testbeds and regenerative medicine, exploiting keratin’s cell-adhesive peptide motifs (LDV, EDS) that human integrin receptors recognize.
3. Wound dressings and medical sponges: biodegradable, highly biocompatible keratin-based dressings that stimulate epithelial regeneration in chronic wounds and burns.
4. Cosmetic and coating ingredients: hydrolyzed keratin as a B2B ingredient for haircare/skincare formulations and as a functional filler in industrial coatings.

Sectoral value chain

[Feather/Wool Collection & Degreasing] ──> [Reductive Keratin Extraction (urea, thiols)] ──> [Dialysis & Concentration]
                                                                                                        │
                                                                                              (Purified keratin protein)
                                                                                                        │
                                                                                                        ▼
[Wound Dressings / Cosmetic B2B Feedstock] <─── [Forming: Film Casting, Gel Lyophilization]

Value chain levels

Cross-cutting technologies of the sector:

• Reductive keratin extraction (sulfitolysis/reduction): cleaving the protein’s cysteine disulfide bridges with thiol reagents or sodium sulfite in concentrated urea, converting rigid feather keratin into a soluble form without peptide-chain degradation.
• Keratin nanofiber electrospinning: drawing a keratin solution through a high-voltage electric field (up to 30 kV) to produce nonwoven membranes with pore sizes under 100 nm.
• Keratin 3D bioprinting: formulating keratin-based bio-inks for additive manufacturing of tissue-engineering scaffolds and skin equivalents.

02US

The US leads commercialization of keratin-based wound dressings and advanced hemostatic products.

commercial keratin wound care, FDA-cleared medical products, defense-funded field medicine R&D

• Keraplast Technologies: markets Functional Keratin® ingredients across personal care, nutraceuticals and wound care, including keraGEN-IV®, an ingestible keratin-derived peptide product for hair, skin and nail health, alongside its keratin-based wound-care lines.
• Regulatory pathway: keratin-based wound dressings (oxidized “keratose” and reduced “kerateine” forms) have moved through FDA clearance for chronic wound and burn indications.
• Defense-funded R&D: field-medicine research funding from the US Department of Defense supports keratin-based hemostatic and wound-care development.

03CN

China is the world’s largest poultry producer and commands enormous feather feedstock volume, with state research institutes developing green extraction methods and exporting hydrolyzed keratin at scale.

green solvent extraction research, large-scale hydrolyzed keratin export, cosmetic/feed ingredient supply

• Institute of Process Engineering (Chinese Academy of Sciences): operates the world’s first thousand-ton-scale ionic-liquid-based regenerated cellulose fiber project in Henan province and has published research applying similar green-solvent extraction expertise to keratin, including a keratin-reinforced silicone-ionic-liquid elastomer composite for pressure-sensor applications.
• Export-scale hydrolyzed keratin: China exports hydrolyzed keratin at large volume as a B2B ingredient for the cosmetics industry (shampoos, haircare) and as an animal-feed additive.
• Feedstock advantage: China’s position as the world’s largest poultry producer gives domestic processors an outsized feather-feedstock base relative to other regions.

04EU

The EU approaches keratin within its zero-waste and circular bioeconomy strategy, with cosmetics majors and applied-research institutes both active in the space.

zero-waste circular bioeconomy, sustainable cosmetic ingredient sourcing, applied biomaterials research

• L’Oréal: as part of its broader sustainable-sourcing and packaging commitments — including the Kérastase refillable shampoo system (recycled-aluminium bottle plus refill pouch) and its “Join the Refill Movement” campaign — the cosmetics major is part of an industry-wide shift toward recycled and plant-/keratin-derived protein ingredients in haircare formulations.
• Fraunhofer IAP (Germany): has demonstrated keratin as a multifunctional, low-cost filler for industrial coatings and published research on a keratin-based 3D-printed tissue substitute for regenerative medicine.
• Kerax Limited (UK): supplies bulk hot-liquid keratin gel products (its keraGEL® line) derived from wool-processing byproducts, alongside its established lanolin/wool-grease business.

05Leading companies and research institutes

06Tech stack and innovations

Modern keratin processing relies on the following equipment and molecular stack:

1. Reductive disulfide-bond cleavage:
   • Chicken feathers (up to 90% beta-keratin) or sheep wool (alpha-keratin) are treated with thiol reagents (2-mercaptoethanol, dithiothreitol) or sodium sulfite in concentrated urea to break cysteine disulfide bridges, converting the rigid keratin structure into a soluble protein without degrading the peptide chain.
2. Membrane dialysis purification:
   • Tangential-flow ultrafiltration membranes remove residual urea and reducing agent from the crude keratin solution, transferring the purified protein into sterile deionized water.
3. Electrospinning and freeze-drying forming:
   • Purified keratin solution is either electrospun into sub-100nm-pore nonwoven nanofiber membranes or freeze-dried into a light, soluble powder for later reconstitution into gels, films or sponges.

07Value chains and production pipelines

Industrial pipeline for producing soluble kerateine protein from chicken feathers

┌───────────────────────────┐      ┌───────────────────────────┐
│ 1. Feather washing &      │ ───> │ 2. Reductive              │
│    drying                  │      │    destructuring (thiourea)│
└───────────────────────────┘      └───────────────────────────┘
                                                 │
                                                 ▼
┌───────────────────────────┐      ┌───────────────────────────┐
│ 4. Deep dialysis on       │ <─── │ 3. Centrifugation to      │
│    semipermeable membranes │      │    separate residue        │
└───────────────────────────┘      └───────────────────────────┘
              │
              ▼
┌───────────────────────────┐      ┌───────────────────────────┐
│ 5. Freeze-drying to dry   │ ───> │ 6. Milling & sterile      │
│    protein powder           │      │    packaging                │
└───────────────────────────┘      └───────────────────────────┘

Stage 1: Feather washing and preparation

Chicken feathers are washed in hot surfactant solution to remove fat and dirt, sterilized by autoclaving, and milled to 1-2mm particle size.

Stage 2: Reductive destructuring

Milled feathers are reacted in 8M urea with 0.5M 2-mercaptoethanol and 0.1M thiourea for 24 hours at pH 10.5 and 50°C under a nitrogen atmosphere to prevent re-oxidation, cleaving the disulfide bonds and solubilizing the keratin.

Stage 3: Centrifugation and fractionation

The suspension is centrifuged at 8,000 rpm to remove insoluble quill residue, collecting the supernatant containing dissolved kerateine with active sulfhydryl (-SH) groups.

Stage 4: Deep dialysis

The solution is pumped through membrane cassettes with a 10 kDa cutoff to fully remove residual urea and mercaptoethanol, transferring the purified protein into sterile deionized water.

Stage 5: Freeze-drying

The aqueous keratin solution is frozen to -40°C and vacuum-dried in a lyophilizer, yielding a loose white kerateine powder.

Stage 6: Milling and sterile packaging

The freeze-dried powder is milled to a uniform particle size and packaged in sealed, moisture-barrier bags under controlled humidity for later reconstitution into hydrogels, films or B2B ingredient supply.